Compare Humana Inc (HUM) vs State Street SPDR Bloomberg High Yield Bond ETF (JNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs State Street SPDR Bloomberg High Yield Bond ETF — how do they compare? Humana Inc trades at $442.02 (market cap $47.61B), while State Street SPDR Bloomberg High Yield Bond ETF trades at $92.75 (market cap $5.83B). The key difference: Humana Inc is far larger — about 8.2× State Street SPDR Bloomberg High Yield Bond ETF's market cap, and Humana Inc pays a 0.89% dividend while State Street SPDR Bloomberg High Yield Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and State Street SPDR Bloomberg High Yield Bond ETF for 60 Days on average.
| HUM | JNK | |
|---|---|---|
Market Cap | $47.61B | $5.83B |
Volume | 1,827,332 | 4,722,904 |
Sector | Health | Fixed Income |
52-Week High | $409.85 | $98.02 |
52-Week Low | $163.67 | $92.30 |
Typical Hold Time | 53 Days | 60 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
JNK trades at $92.76, down 0.13% with a bearish technical outlook indicated by moving averages. The ETF shows neutral oscillator signals with RSI at oversold levels. Recent corporate actions include consistent $0.53 dividend payments scheduled through October 2026. Market sentiment is influenced by rising bond yields and geopolitical tensions affecting high-yield bond markets.
The high-yield bond ETF faces headwinds from rising interest rates and inflation concerns, though consistent dividend payments provide income support. Key risks include further rate hikes and economic slowdown impacting junk bond performance. Institutional interest remains with recent position increases by asset managers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About State Street SPDR Bloomberg High Yield Bond ETF
JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →
